MedPath
FDA Approval

deferasirox

December 26, 2023

Human Prescription Drug Label

Deferasirox(125 mg in 1 1)

Manufacturing Establishments (1)

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries, Inc.

650445203

Products (3)

deferasirox

62756-568

ANDA209782

ANDA (C73584)

ORAL

December 26, 2023

Code: V8G4MOF2V9Class: ACTIBQuantity: 125 mg in 1 1
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MKClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

deferasirox

62756-570

ANDA209782

ANDA (C73584)

ORAL

December 26, 2023

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MKClass: IACT
Code: V8G4MOF2V9Class: ACTIBQuantity: 500 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT

deferasirox

62756-569

ANDA209782

ANDA (C73584)

ORAL

December 26, 2023

Code: V8G4MOF2V9Class: ACTIBQuantity: 250 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MKClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath